What is NDC 0944-2513?

0944-2513 is the product NDC for Hyqvia kit, listed with the FDA by Takeda Pharmaceuticals America, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Hyqvia (Immune Globulin Infusion (Human), 10% with Recombinant Human Hyaluronidase).

Takeda Pharmaceuticals America, Inc., NDC labeler code 0944. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Hyqvia?

4 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Hyqvia NDC 0944-2513 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0944-2513Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00944-2513Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0944-2513-02	0094425130200944251302	1 KIT in 1 CARTON (0944-2513-02) * 200 mL in 1 VIAL, GLASS (0944-2718-20) * 10 mL in 1 VIAL, GLASS (0944-2723-03)Marketed from Sep 12, 2014

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Hyqvia
Generic name (nonproprietary): immune globulin infusion (human), 10% with recombinant human hyaluronidase
Dosage form: Kit
Labeler: Takeda Pharmaceuticals America, Inc.NDC labeler code 0944
Product type: Plasma derivative
Marketing category: BLA — Biologics License ApplicationApplication BLA 125402
Marketing start: Sep 12, 2014
Listing expires: Dec 31, 2027
Identifiers: Product ID 0944-2513_23f408f3-d160-4864-afe2-8d112a951887SPL ID 23f408f3-d160-4864-afe2-8d112a951887

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N400944251302 followed by a unit qualifier and the quantity

Package 00944-2513-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 0944-2513

What is NDC 0944-2513?: 0944-2513 is the product NDC for Hyqvia kit, listed with the FDA by Takeda Pharmaceuticals America, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Hyqvia (Immune Globulin Infusion (Human), 10% with Recombinant Human Hyaluronidase).
Who is the labeler?: Takeda Pharmaceuticals America, Inc., NDC labeler code 0944. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Hyqvia?: 4 other product NDCs are listed under this name. See all Hyqvia NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Hyqvia NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Hyqviaimmune globulin infusion (human), 10% with recombinant human hyaluronidase	—	Kit	Takeda Pharmaceuticals America, Inc.	0944-2510	00944-2510-02
Hyqviaimmune globulin infusion (human), 10% with recombinant human hyaluronidase	—	Kit	Takeda Pharmaceuticals America, Inc.	0944-2511	00944-2511-02
Hyqviaimmune globulin infusion (human), 10% with recombinant human hyaluronidase	—	Kit	Takeda Pharmaceuticals America, Inc.	0944-2512	00944-2512-02
Hyqviaimmune globulin infusion (human), 10% with recombinant human hyaluronidase	—	Kit	Takeda Pharmaceuticals America, Inc.	0944-2514	00944-2514-02

Other NDCs under BLA 125402

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under BLA 125402
Product	Strength	Form · route	Labeler	Product NDC
Hyqviaimmune globulin infusion (human), 10% with recombinant human hyaluronidase	—	Kit	Takeda Pharmaceuticals America, Inc.	0944-2510
Hyqviaimmune globulin infusion (human), 10% with recombinant human hyaluronidase	—	Kit	Takeda Pharmaceuticals America, Inc.	0944-2511
Hyqviaimmune globulin infusion (human), 10% with recombinant human hyaluronidase	—	Kit	Takeda Pharmaceuticals America, Inc.	0944-2512
Hyqviaimmune globulin infusion (human), 10% with recombinant human hyaluronidase	—	Kit	Takeda Pharmaceuticals America, Inc.	0944-2514